EU’s von der Leyen: Sealed deal for extra 1.8 billion BioNtech-Pfizer covid vaccine doses

In another encouraging vaccine development from the Old Continent, European Commission President Ursula von der Leyen announced on Saturday that the EU has struck a deal with BioNTech/Pfizer for up to 1.8 billion extra doses of their Covid-19 vaccine.

“Happy to announce that the EU Commission has just approved a contract for guaranteed 900 million doses (+900 million options) with BioNTech/Pfizer for 2021-2023,” European Commission Chief tweeted from an EU summit in Portugal.

von der Leyen has said previously said, “the mRNA technology used by BioNTech/Pfizer and other vaccine-makers has proven safe and effective.”

After a low start to the vaccination campaign, the 27-nation bloc is on track to have 70% of the adult population fully vaccinated by end July.

Articles You May Like

The Top 3 Reasons Most Forex Traders Are Not Profitable
Muted Reactions to SNB and BoE Rate Hikes, Dollar Underperforms
European equities down at the open with bank stocks lower
Gold tumbles Rs 480; silver declines Rs 345
Celsius lawyer and adviser fees on track to reach $144M, community responds

Leave a Reply

Your email address will not be published. Required fields are marked *